Article
FAM120A deficiency improves resistance to cisplatin in gastric cancer by promoting ferroptosis
2 Apr 2024
Abstract excerpt
The occurrence of chemoresistance is an inescapable obstacle affecting the clinical efficacy of cisplatin in gastric cancer (GC). Exploring the regulatory mechanism of cisplatin resistance will help to provide potential effective targets for improving the prognosis of gastric cancer patients. Here, we find that FAM120A is upregulated in GC tissues and higher in cisplatin-resistant GC tissues, and its high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
